• Allosteric PDK4 Inhibitors for Metabolic Disease Interventio

  2026-07-08

  This article examines the discovery and characterization of novel allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, focusing on compound 8c and its metabolic, immunological, and oncological implications. The findings provide a new chemical scaffold for targeting metabolic disease, allergic responses, and cancer, with detailed insights into mechanisms and translational relevance.

• Staurosporine and the Paradox of Apoptosis in Metastatic Can

  2026-07-08

  Explore the dual role of Staurosporine as a broad-spectrum serine/threonine protein kinase inhibitor and apoptosis inducer in cancer cell lines. This in-depth analysis connects kinase inhibition, recent metastasis research, and practical protocols, providing new insight for advanced cancer research applications.

• Tapuy Lees Attenuate Neurodegeneration in C. elegans Disease

  2026-07-07

  The study by Remucal et al. demonstrates that Tapuy lees, a by-product of traditional Filipino rice wine, significantly reduce amyloid-β toxicity and dopaminergic neuronal loss in C. elegans models of Alzheimer's and Parkinson's diseases. These findings highlight the neuroprotective and antioxidant potential of indigenous food-derived extracts in preclinical neurodegeneration research.

• 25-Hydroxycholesterol Drives AMPKα Activation in Tumor Macro

  2026-07-07

  Xiao et al. (2024) reveal how lysosomal 25-hydroxycholesterol modulates macrophage immunosuppression by activating AMPKα through a GPR155–mTORC1 pathway, ultimately enhancing STAT6-dependent gene expression. This mechanistic insight highlights metabolic reprogramming as a regulatory axis in tumor immunity and suggests new strategies for targeting tumor-associated macrophages.

• FAISL lncRNA Prevents FAK Proteolysis to Drive TNBC Metastas

  2026-07-06

  The reference study identifies the long noncoding RNA FAISL as a direct stabilizer of focal adhesion kinase (FAK) in triple negative breast cancer (TNBC), blocking Calpain 2-mediated proteolysis and promoting tumor progression. These findings illuminate a previously unrecognized mechanism of FAK regulation in cancer and suggest new therapeutic targets for aggressive breast tumors.

• HATU in Peptide Synthesis: Mechanism, Evidence & Workflow In

  2026-07-06

  HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) is a highly efficient amide bond formation reagent. Its use in peptide synthesis delivers rapid, high-yield coupling with precise carboxylic acid activation. APExBIO's HATU (SKU A7022) is validated for reliable, reproducible results in advanced research workflows.

• Applied Workflows with EZ Cap™ Human PTEN mRNA (ψUTP) Delive

  2026-07-05

  EZ Cap™ Human PTEN mRNA (ψUTP) empowers robust PTEN restoration and immune-evasive gene expression in translational cancer research. Its Cap 1 structure and pseudouridine modifications uniquely support advanced, stable mRNA delivery for resistance-reversal oncology workflows.

• Synergistic Inhibition of Melanogenesis by GRE: Mechanisms a

  2026-07-04

  This study demonstrates that a combination of glabridin, resveratrol, and ellagic acid (GRE) potently inhibits melanin production, tyrosinase activity, and associated pro-melanogenic signaling in vitro. By targeting MITF and CREB pathways, GRE provides a mechanistic rationale for its application in pigmentation regulation and anti-inflammatory research.

• Salinomycin: Polyether Ionophore Antibiotic for HCC Research

  2026-07-03

  Salinomycin, a polyether ionophore antibiotic from APExBIO, is redefining hepatocellular carcinoma workflows by targeting the Wnt/β-catenin pathway and inducing apoptosis with high specificity. This guide translates evidence-backed protocols and troubleshooting strategies into actionable insights for robust cancer research.

• Z-DEVD-FMK: Advancing Caspase-3 Inhibition for Translational

  2026-07-03

  Z-DEVD-FMK, a benchmark caspase-3 inhibitor from APExBIO, is redefining translational research in apoptosis and neuroprotection. By integrating mechanistic insight—such as cross-talk between caspase and calpain pathways—with strategic workflow guidance, this article bridges foundational cell death biology with actionable experimental design. We contextualize Z-DEVD-FMK’s dual inhibition in the emerging landscape of viral immunoevasion, spotlighting its role in SADS-CoV infection models, and provide protocol and experimental optimization tips for translational researchers.

• Nutlin-3a: Potent MDM2 Inhibitor for p53 Pathway Activation

  2026-07-02

  Nutlin-3a is a highly specific small-molecule MDM2 inhibitor that stabilizes and activates p53, resulting in controlled cell cycle arrest and apoptosis induction in cancer cells. It demonstrates sub-micromolar potency and robust experimental utility in oncology research. This dossier summarizes its mechanism, experimental benchmarks, and best practices.

• ECL Chemiluminescent Substrate Detection Kit: Transforming Q

  2026-07-02

  Explore the unique capabilities of the ECL Chemiluminescent Substrate Detection Kit (Enhanced) for advanced protein immunodetection. This article reveals how its high sensitivity and prolonged luminescence enable robust, quantitative insights in metabolic and translational research.

• NET Formation in CML: PAD4 Dependency and Tyrosine Kinase In

  2026-07-01

  This study reveals that neutrophil extracellular trap (NET) formation is significantly elevated in chronic myeloid leukemia (CML) and is further modulated by tyrosine kinase inhibitors (TKIs), particularly ponatinib. The research highlights PAD4-driven histone citrullination as a mechanistic driver of NET production, suggesting new therapeutic and risk-assessment considerations for CML and TKI-associated vascular complications.

• CARD8 Inflammasome Activation Induces Pyroptosis in Human T

  2026-07-01

  The referenced study reveals that inhibition of dipeptidyl peptidases, particularly with Val-boroPro (Talabostat mesylate), activates the CARD8 inflammasome and triggers pyroptosis in primary human T cells. These findings expand the known landscape of inflammasome signaling and suggest new mechanistic routes for modulating T cell fate in immunology and cancer research.

• Ouabain as a Selective Na⁺/K⁺-ATPase Inhibitor: Bridging Ion

  2026-06-30

  Explore the scientific foundation and innovative applications of Ouabain, a selective Na⁺/K⁺-ATPase inhibitor, in advanced ion transport and senescence research. This article delivers unique insights into integrating recent senolytic discoveries with practical assay design, setting it apart from existing reviews.

15578 records 1/1039 page Next 12345 下5页 Last page